Format

Send to

Choose Destination
Card Electrophysiol Clin. 2016 Mar;8(1):233-7. doi: 10.1016/j.ccep.2015.10.035.

Catecholaminergic Polymorphic Ventricular Tachycardia.

Author information

1
Cardiology, Department of Internal Medicine, American University of Beirut Faculty of Medicine and Medical Center, PO Box 11-0236, Riad El-Solh, Beirut 1107 2020, Lebanon; Department of Biochemistry and Molecular Genetics, American University of Beirut Medical Center, Beirut, Lebanon. Electronic address: mr48@aub.edu.lb.
2
Department of Biochemistry and Molecular Genetics, American University of Beirut Medical Center, Beirut, Lebanon.
3
Division of Cardiology, Department of Medicine, University of California San Francisco Medical Center, San Francisco, CA, USA.

Abstract

Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a challenging and serious disease with a high incidence of sudden cardiac deaths. Patients with CPVT should not be exposed to physical or emotional exertion that might induce ventricular tachycardia. This article presents a case with CPVT and discusses the clinical features of the disease, its genetic background, and the management of CPVT.

KEYWORDS:

Cardiac; Catecholaminergic; Polymorphic; Ventricular tachycardia

PMID:
26920200
DOI:
10.1016/j.ccep.2015.10.035
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center